Furthermore, Vascular Endothelial Growth Factor A (VEGFA) is also an inducer of angiogenesis and tumor necrosis in HCC, and the silencing of VEGFA has been proposed as a therapeutic strategy for HCC [31]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.